Innovation Theaters

Friday, December 10, 2021

12:35 PM

Clinical Consistency: A commitment to evolving and elevating care for patients with moderate to severe Crohn’s disease

Asher Kornbluth, MD

Presented by:

" "

 

12:35 PM

A Once-daily Oral S1P Receptor Modulator for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adults.

Matthew Ciorba, MD, AGAF

Presented by:

" "

 

12:35 PM

Clinical Overview of a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis

Bincy Abraham, MD

Presented by:

" "

 

12:35 PM

Achieving Long-Term Clinical Remission in Moderate to Severe CD

Stephen B. Hanauer, MD

Presented by:

" "

 

6:15 PM

Gut Decisions - Which ulcerative colitis symptom impacts your patient the most?

Bincy P. Abraham, MD

Presented by:

" "